A derivative of dihydrotestosterone, stanozolol possesses fewer androgenic characteristics than DHT. The anabolic properties are also less in comparison to stronger compounds, but stanozolol is still known as a nice solid muscle builder, which exhibits much less water retention than the likes of dianabol. This compound is also referred to as 'winstrol', or 'winny', winstrol being a popular brand of stanozolol. Stanozolol has the same c17 methylation that is seen in the likes of dianabol, which makes oral administration possible.
As this steroid possesses no capabilities to convert to oestrogen, related side effects are often not of a concern to the user. An anti-oestrogen is not needed during a winny cycle to combat related side effects, and the build up of subcutaneous fluid is of no concern.
For these reasons, this compound is very appealing for those who want a steroid during their cutting phase, when water retention is not wanted. Stanozolols abilities to increase strength and power whilst keeping added subcutaneous fluid to a minimum are also favoured characteristics to track and field athletes (Ben Johnson infamously tested positive for winstrol after the 1988 Seoul Olympics 100m final).
40-80mg is a common dose for oral administration, with 50-100mg being the norm for the injectable version. The goals of the user will determine what compounds stanozolol should be stack with. During bulking cycles stanozolol can provide the user with a compound which will heighten the anabolic effects of their cycle, whilst not adding to the oestrogen activity experienced from other aromatising compounds, such as testosterone. Stanozolol is obviously a great choice for those who wish to implement the compound during cutting phases, and may wish to stack the compound with the likes of trenbolone. This will give the user a very solid and defined appearance due to low levels of subcutaneous fluid, and the abilities of both the compounds to create a look which is very sought after by a bodybuilder.
Being a 17aa structured steroid we can expect stress to be placed on the liver during use of oral stanozolol. This is more commonly experienced with the tablet form of the drug, but with higher and sustained use of the injectable form some stress can also be experienced as the liver breaks the substance down. It is therefore advised to keep duration and dose of the drug within suitable margins to minimise stress, and the employment of a liver protection supplements may be wise.
The oral version of stanozolol can also be worse in regards to an alteration of HDL/LDL cholesterol levels. It is therefore important to keep this in mind when choosing this compound, and with dosage and duration of use.
100mg/ml Stanozolol Suspension